In opening statements in its lawsuit against Johnson & Johnson for lying about Risperdal’s risks and promoting its use for unapproved treatments, Arkansas’ lawyer Fletch Trammell said that the drug had caused deaths among elderly users and breast growth and lactation in young boys. If found guilty, Arkansas’ Medicaid fund could receive from $1.25 to $2.5 billion.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.